Concepedia

Valerie Roman

VR

Statistics

Publications

4

Citations

94

H-Index

4

Active since

2018

Affiliations

Incyte (United States)(Current)

Valerie Roman is an author at Incyte (United States) specializing in oncology, anticancer activity, and pharmacology.

Publications per year

2018–2025

4

Publications

4

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies

Holly K. Koblish, Yunlong Li, Niu Shin et al. · PLoS ONE · 2018 · 54 citations · Full text

, , +15

Discovery of (4-Pyrazolyl)-2-aminopyrimidines as Potent and Selective Inhibitors of Cyclin-Dependent Kinase 2

Joshua R. Hummel, Kai‐Jiong Xiao, Jeffrey Yang et al. · Journal of Medicinal Chemistry · 2024 · 15 citations · Full text

, , +15

Abstract 5900: INCB161734: A novel, potent, and orally bioavailable KRAS G12D selective inhibitor demonstrates antitumor activity in <i>KRAS G12D</i> mutant tumors

Matthew R. Farren, Valerie Roman, Alexandra Gallion et al. · Cancer Research · 2024 · 13 citations

, , +15

Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor

Qinda Ye, Artem Shvartsbart, Zhenwu Li et al. · Journal of Medicinal Chemistry · 2025 · 12 citations

, , +14

1–4 of 4